Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Biobehavioral Intervention in Gynecologic Oncology Patients [Phase 2]
Phase 2 clinical trial of a biobehavioral intervention in gynecologic oncology patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating intraperitoneal natural killer cells in combination with INCB024360 for recurrent ovarian, fallopian tube, and pr…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial update across multiple cancer types including ovarian, non-small cell lung, prostate, colorectal, gastric/esophageal,…
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2) [Phase 3]
The Phase 3 TRINOVA-2 trial of trebananib (AMG 386) in fallopian tube cancer, ovarian cancer, and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy [NA]
A completed clinical trial evaluating mindfulness-based cancer recovery after chemotherapy across breast, colorectal, ovarian, and uterine c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer [Phase 1]
A Phase 1 trial evaluating a cancer vaccine therapy in combination with sargramostim has completed in patients with stage III or IV cancer, …
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial assessing the safety and dosing of the combination of bortezomib and gemcitabine in older patients with advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer [Phase 1]
Update on a Phase 1 trial of docetaxel in patients with refractory or recurrent advanced gynecologic cancers, with the study status marked a…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 trial of topotecan in fallopian tube cancer, ovarian cancer, or primary peritoneal cancer; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors [Phase 1]
A Phase 1 trial evaluating amifostine to protect against side effects of peripheral stem cell transplantation in patients with solid tumors …
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: A Survivorship Care Plan for Gynaecological Cancer Patients
This completed clinical trial update reports on a survivorship care plan study for gynecologic cancer patients sponsored by Royal Marsden NH…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial of enzastaurin in patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer has co…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors [Phase 1]
This Phase 1 study evaluated the effects of Veliparib on heart rhythms in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer [Phase 1]
Phase 1 trial update evaluating Veliparib in combination with carboplatin and weekly paclitaxel in Japanese patients with ovarian cancer; th…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer [Phase 1]
An open-label Phase 1 study evaluating the pharmacokinetics and pharmacodynamics of repeat escalating oral doses of the AKT inhibitor GSK214…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer [NA]
This study assessed intraoperative detection of cancer lesions using a PET probe during secondary cytoreductive surgery for recurrent ovaria…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy [NA]
This clinical trial update summarizes psychosexual outcomes observed after risk-reducing salpingo-oophorectomy in individuals at risk for ov…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors [Phase 2]
Phase 2 trial of combination chemotherapy with pegfilgrastim in previously untreated germ cell tumors has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-10-02Clinical Trial Update: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating recombinant measles virus vaccine therapy and oncolytic virus therapy for progressive, recurrent, or refra…
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating apatinib plus etoposide versus etoposide alone for platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) [Phase 2]
Phase 2 study evaluating adavosertib in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in platinum-sensitive …
-
CLINICAL_TRIALS trial_result · 2017-09-07Clinical Trial Update: Rilotumumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of rilotumumab in persistent/recurrent ovarian, fallopian tube, or primary peritoneal cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission [Phase 2]
Phase 2 clinical trial evaluating OPT-821 with or without vaccine therapy in ovarian, fallopian tube, or primary peritoneal cancer in second…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids [Phase 1]
Phase 1 trial evaluating a combination of carboplatin, paclitaxel (Taxol), and ridaforolimus in endometrial and ovarian cancers; study statu…